Research suggests that institutions limit the extent to which efficient policies to reduce greenhouse gas emissions are likely to be adopted.

Re-regulation could have unintended consequences and undermine America's competitive position in theglobal market for financial services.

Paul L. Joskow is president of the Alfred P. Sloan Foundation and presently on leave from MIT, where he is the Elizabeth and James Killian Professor of Economics and Management. His lecture will review the broad experience with deregulation, regulatory reform, and industry restructuring in the United States over the...

The crisis in financing is having a chilling effect on biomedical innovation. As discussed in my last column, the main problem in our industry is that the sheer cost of drug development has become almost prohibitively expensive, effectively pricing almost everyone but the largest companies out of the market.

Cass R. Sunstein, professor of law at the University of Chicago Law School, will deliver the first Distinguished Lecture of the new AEI Center for Regulatory and Market Studies. His subject will be the sources of extremism. He uses recent studies of juries, federal judges, and ordinary citizens to show...

The trade in inferior quality medicines kills innocent patients. Perhaps 15 percent of the global drug supply outside of advanced countries is counterfeit, rising in certain markets in parts of Africa and Asia to over 50 percent. But counterfeits are not the only low-quality drugs on the market.

Washington has many agencies with specialized jurisdiction over particular markets or issues. Competition is important and desirable in all of these markets. Economic theory, backed by numerous studies, predicts that increased competition and the ensuing market forces work best for meeting consumer needs. Regulatory agencies differ, however, in the extent...

This event will discuss the myths and realities of deregulation during the Bush 43 years.